Reversal of Streptozotocin-Induced Diabetes in Mice by Cellular Transduction with Recombinant Pancreatic Transcription Factor Pdx1 - A Novel Protein Transduction Domain Based Therapy

  1. Vijay Koya1,
  2. Lu Shun1,
  3. Yu-Ping Sun1,
  4. Daniel L. Purich2,
  5. Mark A. Atkinson1,
  6. Shi-Wu Li1 and
  7. Li-Jun Yang (yanglj{at}pathology.ufl.edu)1
  1. 1Department of Pathology, Immunology, and Laboratory Medicine and
  2. 2Department of Biochemistry and Molecular Biology, University of Florida College of Medicine, Gainesville, Florida 32610

    Abstract

    Objective: The key pancreatic transcription factor Pdx1, known to control development and maintenance of pancreatic β-cells, possesses a protein transduction domain (PTD) that facilitates its entry into cells. We therefore sought to evaluate the capacity of in vivo-administered recombinant Pdx1 (rPdx1) to ameliorate hyperglycemia in a streptozotocin (Stz)-induced diabetic mice.

    Research Design and Methods: Cell entry and transcriptional regulatory properties of rPdx1 and its PTD-deletion mutant rPdx1Δ, as well as a PTD-GFP reporter protein were evaluated in vitro. After intraperitoneal rPdx1 injection into Stz-diabetic mice, we assessed the its action on blood glucose levels, insulin content, and IPGTT, as well as Pdx1 distribution, pancreatic gene expression, islet cell proliferation, and organ histology.

    Results: Restoration of euglycemia in Pdx1-treated diabetic mice was evident by improved IPGTT and glucose-stimulated insulin release. Insulin-, glucagon-, and Ki67-immunostaining revealed increased islet cell number and proliferation in pancreata of rPdx1-treated mice. Real-time PCR of pancreas and liver demonstrated up-regulation of INS and PDX1 genes as well as other genes relevant to pancreas regeneration. While the time-course of β-cell gene expression and serum/tissue insulin levels indicated that liver- and pancreas-derived insulin contributed to restoration of normoglycemia, near-total pancreatectomy resulted in hyperglycemia, suggesting that β-cell regeneration played the primary role in rPdx1-induced glucose homeostasis.

    Conclusions: rPdx1 treatment of Stz/diabetic mice promotes β-cell regeneration and liver-cell reprogramming, leading to restoration of normoglycemia. This novel PTD-based protein therapy offers a promising way to treat patients with diabetes, while avoiding potential side-effects associated with the use of viral vectors.

    Footnotes

      • Received October 9, 2007.
      • Accepted December 7, 2007.